Skip to main content

Genesis Medtech

Genesis MedTech Group is a medical device company, founded by a group of professionals and entrepreneurs with MedTech experience globally and in Asia. The company’s business focuses on R&D, manufacturing and marketing of high-value medical consumables with sales and distribution through its established commercial network. The company’s franchises include Surgical, Vascular Interventions (Cardiovascular, Peripheral Vascular and Neurovascular) and Structural Heart.
Genesis MedTech has since established R&D centers in China, the United States, Japan and Singapore, and collaborates with first-class R&D teams from all over the world. The company is committed to establishing an innovation network on a global scale to continuously innovate and improve technology.
In Sept. 2022, Genesis MedTech completed the first phase of its Wuxi Campus. The project consists of two R&D and manufacturing buildings and an innovation center. The R&D and manufacturing center is constructed to independently develop and manufacture high-quality medical devices, with a focus on cutting-edge medical products.
The company has built strong commercial capabilities and a nationwide distribution network, covering about 2000 domestic hospitals.
Its vision is to create an open medical technology platform, integrate multiple partners to create value together, and become an innovative world-class enterprise. Its mission is to make MedTech available and affordable to patients: better health for better life.